Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid

Cancer is a mortality contributor worldwide, and breast cancer is the most common among women. Despite the numerous breast cancer therapeutic strategies, they either have limitations or sometimes are resisted by cancer, so new approaches are needed to tackle those restrictions. Nanotechnology offers...

Full description

Bibliographic Details
Main Authors: Sawsan M El-sonbaty, Fatma SM Moawed, Eman I Kandil, Amira M Tamamm
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/15593258211068998
_version_ 1818294080591888384
author Sawsan M El-sonbaty
Fatma SM Moawed
Eman I Kandil
Amira M Tamamm
author_facet Sawsan M El-sonbaty
Fatma SM Moawed
Eman I Kandil
Amira M Tamamm
author_sort Sawsan M El-sonbaty
collection DOAJ
description Cancer is a mortality contributor worldwide, and breast cancer is the most common among women. Despite the numerous breast cancer therapeutic strategies, they either have limitations or sometimes are resisted by cancer, so new approaches are needed to tackle those restrictions. Nanotechnology offers exciting leaps in the diagnosis and treatment of cancer, especially breast cancer. The main objective of this study was to investigate the effect of the newly synthesized gallium nanoparticles coated by Ellagic acid (EA-GaNPs) on the induced mammary gland carcinogenesis in female rats and their antibacterial activities comparison with standard antibiotics (Ketoconazole (100 μg/ml) and Gentamycin (4 μg/ml)) by disc diffusion method using eight different microbial species. The antitumor efficacy of EA-GaNPs was conducted both in vitro and in in vivo. The result of antimicrobial activity of EA-Ga NPs (1 mg/1 mL) revealed moderate toxicity behavior against Gram-positive {Staphylococcus aureus, Bacillus subtilis, Bacillus cereus) and Gram-negative pathogenic bacteria {Escherichia coli, Proteus vulgarfs) also, antifungal activity was detected against {Aspergillus terreus). In vitro study showed that EA-GaNPs inhibited human breast cancer cell line (MCF-7) proliferation with IC50 of 2.86 μg/ml. Although in vivo; the administration of EA-GaNPs to DMBA-treated rats ameliorated the hyperplastic state of mammary gland carcinogenesis induced by DMBA. Additionally, EA-GaNPs administration significantly modulated the activities of ALT and AST, as well as the levels of urea and creatinine in serum. Also, EA-GaNPs administration improved the antioxidant state by increasing Superoxide dismutase activity and GSH content, and decreasing malondialdehyde content in the mammary tissue, besides enhancing the apoptotic activity through elevating the levels of caspase-3 and decreasing the protein intensities of protein kinase B & phosphatidyl inositide 3-kinases. Furthermore, a significant decrease in serum Total iron-binding capacity accompanied by a significant increase in the level of calcium was noted. So, it can be concluded that the newly synthesized nanoparticles EA-GaNPs have an efficient antitumor activity that was manifested by reduction of the viability on the human breast cancer cell line (MCF-7) in vitro. Also, in vivo against the chemically induced mammary gland carcinogenesis in a female rat model. Histopathological findings were in harmony with biochemical and molecular results showing the effectiveness of EA-GaNPs against mammary carcinogenesis. Therefore, EA-GaNPs could be a promising, potent anti-cancer compound.
first_indexed 2024-12-13T03:26:04Z
format Article
id doaj.art-2181fe7a60cd47bf950a2f067f4c2015
institution Directory Open Access Journal
issn 1559-3258
language English
last_indexed 2024-12-13T03:26:04Z
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series Dose-Response
spelling doaj.art-2181fe7a60cd47bf950a2f067f4c20152022-12-22T00:01:16ZengSAGE PublishingDose-Response1559-32582022-01-012010.1177/15593258211068998Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic AcidSawsan M El-sonbatyFatma SM MoawedEman I KandilAmira M TamammCancer is a mortality contributor worldwide, and breast cancer is the most common among women. Despite the numerous breast cancer therapeutic strategies, they either have limitations or sometimes are resisted by cancer, so new approaches are needed to tackle those restrictions. Nanotechnology offers exciting leaps in the diagnosis and treatment of cancer, especially breast cancer. The main objective of this study was to investigate the effect of the newly synthesized gallium nanoparticles coated by Ellagic acid (EA-GaNPs) on the induced mammary gland carcinogenesis in female rats and their antibacterial activities comparison with standard antibiotics (Ketoconazole (100 μg/ml) and Gentamycin (4 μg/ml)) by disc diffusion method using eight different microbial species. The antitumor efficacy of EA-GaNPs was conducted both in vitro and in in vivo. The result of antimicrobial activity of EA-Ga NPs (1 mg/1 mL) revealed moderate toxicity behavior against Gram-positive {Staphylococcus aureus, Bacillus subtilis, Bacillus cereus) and Gram-negative pathogenic bacteria {Escherichia coli, Proteus vulgarfs) also, antifungal activity was detected against {Aspergillus terreus). In vitro study showed that EA-GaNPs inhibited human breast cancer cell line (MCF-7) proliferation with IC50 of 2.86 μg/ml. Although in vivo; the administration of EA-GaNPs to DMBA-treated rats ameliorated the hyperplastic state of mammary gland carcinogenesis induced by DMBA. Additionally, EA-GaNPs administration significantly modulated the activities of ALT and AST, as well as the levels of urea and creatinine in serum. Also, EA-GaNPs administration improved the antioxidant state by increasing Superoxide dismutase activity and GSH content, and decreasing malondialdehyde content in the mammary tissue, besides enhancing the apoptotic activity through elevating the levels of caspase-3 and decreasing the protein intensities of protein kinase B & phosphatidyl inositide 3-kinases. Furthermore, a significant decrease in serum Total iron-binding capacity accompanied by a significant increase in the level of calcium was noted. So, it can be concluded that the newly synthesized nanoparticles EA-GaNPs have an efficient antitumor activity that was manifested by reduction of the viability on the human breast cancer cell line (MCF-7) in vitro. Also, in vivo against the chemically induced mammary gland carcinogenesis in a female rat model. Histopathological findings were in harmony with biochemical and molecular results showing the effectiveness of EA-GaNPs against mammary carcinogenesis. Therefore, EA-GaNPs could be a promising, potent anti-cancer compound.https://doi.org/10.1177/15593258211068998
spellingShingle Sawsan M El-sonbaty
Fatma SM Moawed
Eman I Kandil
Amira M Tamamm
Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
Dose-Response
title Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
title_full Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
title_fullStr Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
title_full_unstemmed Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
title_short Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid
title_sort antitumor and antibacterial efficacy of gallium nanoparticles coated by ellagic acid
url https://doi.org/10.1177/15593258211068998
work_keys_str_mv AT sawsanmelsonbaty antitumorandantibacterialefficacyofgalliumnanoparticlescoatedbyellagicacid
AT fatmasmmoawed antitumorandantibacterialefficacyofgalliumnanoparticlescoatedbyellagicacid
AT emanikandil antitumorandantibacterialefficacyofgalliumnanoparticlescoatedbyellagicacid
AT amiramtamamm antitumorandantibacterialefficacyofgalliumnanoparticlescoatedbyellagicacid